EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Alderyra Therapeutics, Inc. dated as of January 22, 2018 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(2) under the Securities Exchange Act of 1934, as amended.

Dated: January 22, 2018

683 CAPITAL MANAGEMENT, LLC

By:  /s/ Ari Zweiman      Ari Zweiman,      Authorized Person

683 CAPITAL PARTNERS, LP

By:  /s/ Ari Zweiman      Ari Zweiman,      Authorized Person

/s/ Ari ZweimanARI ZWEIMAN